title: The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood.
abstract: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) are among the most common malignancies of childhood. (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) can be employed for accurate staging, treatment planning, and response assessment in pediatric patients with lymphomas, taking advantage of the increased FDG uptake of the malignant cells, secondary to their increased metabolic needs. FDG PET has higher sensitivity than other imaging modalities to detect nodular or diffuse lesions and higher sensitivity than bone marrow biopsy to detect bone marrow infiltration. FDG PET consists of an invaluable imaging modality during evaluation and treatment of pediatric lymphomas.
authors.affiliation: Neurosurgical Research Institute, University of Ioannina, Ioannina 45500, Greece. csioka@yahoo.com
authors.forename: Chrissa
authors.initials: C
authors.lastname: Sioka
mesh_terms: D059248:Chemoradiotherapy; D002648:Child; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
references.citation: Paediatr Drugs. 2010 Apr 1;12(2):85-98
references.pmid: 20218745
references.citation: Pediatr Blood Cancer. 2004 Jul;43(1):8-16
references.pmid: 15170884
references.citation: Leuk Lymphoma. 2007 Apr;48(4):699-707
references.pmid: 17454627
references.citation: Pediatr Hematol Oncol. 2012 Mar;29(2):109-18
references.pmid: 22376014
references.citation: Clin Nucl Med. 2012 Jul;37(7):656-62
references.pmid: 22691506
references.citation: Pediatr Blood Cancer. 2012 Jun;58(6):860-4
references.pmid: 21826784
references.citation: J Pediatr Hematol Oncol. 2011 Mar;33(2):e60-3
references.pmid: 21285900
references.citation: Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e667-71
references.pmid: 21459527
references.citation: Strahlenther Onkol. 2012 Jun;188(6):464-70
references.pmid: 22349634
references.citation: Pediatr Radiol. 2006 Jun;36(6):524-31
references.pmid: 16622665
references.citation: J Clin Oncol. 1989 Nov;7(11):1630-6
references.pmid: 2809679
references.citation: Nuklearmedizin. 2005 Feb;44(1):1-7
references.pmid: 15711722
references.citation: N Engl J Med. 1996 May 9;334(19):1238-48
references.pmid: 8606720
references.citation: Radiographics. 2003 Mar-Apr;23(2):315-40; quiz 533
references.pmid: 12640150
references.citation: Pediatr Blood Cancer. 2008 Aug;51(2):198-203
references.pmid: 18428430
references.citation: Pediatr Blood Cancer. 2012 Sep;59(3):475-80
references.pmid: 22190514
references.citation: Pediatr Blood Cancer. 2006 Jan;46(1):26-34
references.pmid: 16161019
references.citation: J Clin Oncol. 2009 Sep 10;27(26):4385-91
references.pmid: 19667276
references.citation: J Nucl Med Technol. 2012 Mar;40(1):13-24
references.pmid: 22393223
references.citation: Ann Nucl Med. 2013 Feb;27(2):146-51
references.pmid: 23143537
references.citation: Radiol Clin North Am. 2008 Mar;46(2):313-38, ix
references.pmid: 18619383
references.citation: Semin Radiat Oncol. 2007 Jul;17(3):230-42
references.pmid: 17591570
references.citation: Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1469-76
references.pmid: 21505896
references.citation: J Clin Endocrinol Metab. 2000 Sep;85(9):3227-32
references.pmid: 10999813
references.citation: J Nucl Med. 2009 Oct;50(10):1570-7
references.pmid: 19793734
references.citation: Blood. 2012 May 3;119(18):4129-32
references.pmid: 22343727
references.citation: N Engl J Med. 1990 Jan 4;322(1):7-13
references.pmid: 2403650
references.citation: J Clin Oncol. 2011 Sep 10;29(26):3523-8
references.pmid: 21825262
references.citation: Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):31-8
references.pmid: 15605288
references.citation: J Clin Oncol. 1999 Dec;17(12):3736-44
references.pmid: 10577845
references.citation: J Pediatr Hematol Oncol. 2006 Nov;28(11):711-4
references.pmid: 17114956
references.citation: Cancer Biother Radiopharm. 2008 Dec;23(6):681-90
references.pmid: 19111053
references.citation: Cancer. 1991 Dec 1;68(11):2478-80
references.pmid: 1933785
references.citation: Pediatr Blood Cancer. 2012 May;58(5):665-74
references.pmid: 22232079
references.citation: Med Pediatr Oncol. 1996 Aug;27(2):74-8
references.pmid: 8649323
references.citation: Pediatr Radiol. 2005 Feb;35(2):141-54
references.pmid: 15654605
references.citation: Lancet. 2005 Jun 11-17;365(9476):2014-23
references.pmid: 15950715
references.citation: J Clin Oncol. 2002 Aug 15;20(16):3484-94
references.pmid: 12177110
references.citation: J Pediatr Hematol Oncol. 2008 May;30(5):343-6
references.pmid: 18458566
references.citation: J Clin Oncol. 1996 Sep;14(9):2473-9
references.pmid: 8823325
references.citation: J Clin Oncol. 2004 Aug 1;22(15):3139-48
references.pmid: 15284266
references.citation: Eur J Cancer. 2001 Apr;37(6):678-86
references.pmid: 11311641
references.citation: Eur J Cancer. 2012 Jan;48(1):108-13
references.pmid: 21703849
references.citation: Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1155-65
references.pmid: 12192560
references.citation: Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):24-33
references.pmid: 18722263
references.citation: Radiology. 2000 Jan;214(1):253-7
references.pmid: 10644133
references.citation: J Comput Assist Tomogr. 2006 Jul-Aug;30(4):689-94
references.pmid: 16845304
references.citation: Leuk Lymphoma. 2013 Apr;54(4):737-42
references.pmid: 22957898
references.citation: Pediatr Radiol. 2010 May;40(5):681-6
references.pmid: 19967534
references.citation: Radiology. 2007 Apr;243(1):96-104
references.pmid: 17293575
references.citation: J Clin Oncol. 1997 Apr;15(4):1631-7
references.pmid: 9193363